Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Marijuana Abuse 2Tourette Syndrome 1Stress Disorders, Post-Traumatic 1Sleep Initiation and Maintenance Disorders 1Severe Acute Respiratory Syndrome 1Seizures 1Parkinson Disease 1Pancreatic Cancer Non-resectable 1Pain 1Opioid-Related Disorders 1Neoplasms 1Multiple Sclerosis 1Marijuana Use 1Inflammatory Bowel Diseases 1Hepatitis C 1Glaucoma 1Fibromyalgia 1Epilepsy 1Depression 1Crohn Disease 1Coronavirus Infections 1Colitis, Ulcerative 1Chronic Traumatic Encephalopathy 1Chronic Pain 1Carcinoma, Hepatocellular 1COVID-19 1Brain Injuries, Traumatic 1Bipolar Disorder 1Autistic Disorder 1Anxiety Disorders 1

Interventions

Fentanyl 23Analgesia 22Morphine 19Acupuncture Therapy 18Zoledronic Acid 15Oxycodone 14Acetaminophen 14Ketamine 13Radiotherapy 12Therapeutics 11Methadone 11Lidocaine 11nabiximols 10Ibandronic Acid 10Hydromorphone 10Bupivacaine 10Surveys and Questionnaires 8Ropivacaine 8Psychiatric Rehabilitation 7Early Intervention, Educational 7Saline Solution 6Music Therapy 6Cryotherapy 6Cryosurgery 6Yoga 5Water 5Tapentadol 5Pregabalin 5Methods 5Massage 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pain × Medical Marijuana × Clear all
NCT04827992 2025-11-05

Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain

Massachusetts General Hospital

Phase NA Completed
87 enrolled

Marijuana Use, Marijuana Abuse, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡